Compare OHI & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OHI | ELAN |
|---|---|---|
| Founded | N/A | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2B | 12.7B |
| IPO Year | 2001 | 2018 |
| Metric | OHI | ELAN |
|---|---|---|
| Price | $46.40 | $21.65 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 10 |
| Target Price | ★ $46.55 | $27.89 |
| AVG Volume (30 Days) | 1.9M | ★ 3.8M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 5.74% | N/A |
| EPS Growth | ★ 25.16 | N/A |
| EPS | ★ 0.47 | N/A |
| Revenue | $1,190,099,000.00 | ★ $4,715,000,000.00 |
| Revenue This Year | $4.70 | $8.21 |
| Revenue Next Year | $5.38 | $5.31 |
| P/E Ratio | $24.02 | ★ N/A |
| Revenue Growth | ★ 13.19 | 6.22 |
| 52 Week Low | $35.09 | $9.42 |
| 52 Week High | $49.14 | $27.72 |
| Indicator | OHI | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 53.82 | 36.92 |
| Support Level | $46.49 | $20.73 |
| Resistance Level | $49.13 | $21.76 |
| Average True Range (ATR) | 1.00 | 0.79 |
| MACD | 0.15 | -0.12 |
| Stochastic Oscillator | 56.93 | 2.50 |
Omega Healthcare Investors Inc is a real estate investment trust that invests in healthcare-related real estate properties located in the United States (U.S.), the United Kingdom (U.K.), and Canada. The company's objective is to provide attractive returns to investors while serving as the preferred capital partner to its third-party healthcare operating companies and affiliates, as well as other third-party healthcare operators, allowing them to focus on delivering a high level of care to their resident patients. Omega's investment portfolio mainly consists of skilled nursing facilities, assisted living facilities (ALFs), including care homes in the U.K., independent living facilities, rehabilitation and acute care facilities, and continuing care retirement communities.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.